TELA BIO INC. - COMMON STOCK

TELA Bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

10 May 2024 15:05:00 By Nasdaq GlobeNewswire

TELA Bio Reports First Quarter 2024 Financial Results

09 May 2024 15:05:00 By Nasdaq GlobeNewswire

TELA Bio to Announce First Quarter 2024 Financial Results

25 Apr 2024 06:00:00 By Nasdaq GlobeNewswire

TELA Bio Announces U.S. Commercial Launch of Robotic-Compatible OviTex® IHR – Addressing the Need for a More Natural Repair in Inguinal Hernia Procedures

15 Apr 2024 06:00:00 By Nasdaq GlobeNewswire

TELA Bio Welcomes Acclaimed Surgeon as Vice President of Medical Affairs and Surgeon Strategy

08 Apr 2024 06:00:00 By Nasdaq GlobeNewswire

TELA Bio Achieves Record Fourth Quarter and Full Year 2023 Revenues and Reports Complete Financial Results

21 Mar 2024 15:05:00 By Nasdaq GlobeNewswire

TELA Bio Announces Sale of Distribution Rights for Wound Care Product to MIMEDX

20 Mar 2024 06:00:00 By Nasdaq GlobeNewswire

TELA Bio to Announce Fourth Quarter and Full Year 2023 Financial Results

29 Feb 2024 06:00:00 By Nasdaq GlobeNewswire

TELA Bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

23 Feb 2024 15:05:00 By Nasdaq GlobeNewswire

TELA Bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

19 Jan 2024 15:05:00 By Nasdaq GlobeNewswire

TELA Bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

15 Dec 2023 15:05:00 By Nasdaq GlobeNewswire

TELA Bio to Take Part in Connecting the Dots

05 Dec 2023 06:00:00 By Nasdaq GlobeNewswire

TELA Bio to Participate in Piper Sandler’s 35th Annual Healthcare Conference

16 Nov 2023 06:00:00 By Nasdaq GlobeNewswire

TELA Bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

10 Nov 2023 15:05:00 By Nasdaq GlobeNewswire

TELA Bio Reports Third Quarter 2023 Financial Results

09 Nov 2023 15:05:01 By Nasdaq GlobeNewswire

TELA Bio to Announce Third Quarter 2023 Financial Results

26 Oct 2023 06:00:00 By Nasdaq GlobeNewswire

TELA Bio to Participate in the Gilmartin Group Emerging Growth Company Showcase

18 Sep 2023 15:05:00 By Nasdaq GlobeNewswire

TELA Bio Announces U.S. Commercial Launch of OviTex® PRS Long-Term Resorbable for Plastic and Reconstructive Surgery

16 Aug 2023 06:00:00 By Nasdaq GlobeNewswire

TELA Bio Reports Second Quarter 2023 Financial Results

09 Aug 2023 15:03:00 By Nasdaq GlobeNewswire

TELA Bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

04 Aug 2023 15:02:00 By Nasdaq GlobeNewswire